Research drives excellence in clinical care, increases options for patients, attracts the brightest and best researchers and clinicians and fosters a climate of innovation…
The overall and ambitious aim of the ICORN Network is HCV eradication in Ireland – C it Off 2030. HCV eradication will be enabled by a strong evidence-based research programme, by a quality-assured, cost effective programme, by sustained political advocacy and by the collaborative partnership of clinicians, patients, researchers, grant funders and policy makers, working to this common purpose.
Clinical research provides the opportunity for patients to have early access to new products and to be involved in research studies of innovative agents. The Irish Hepatitis C Outcomes and Research Network (ICORN) affords the opportunity for collaborative, multi-centered, world-class research in patients with hepatitis C in the island of Ireland. ICORN has established a strong platform for clinical research studies by forming strong links with academic investigators and the pharmaceutical industry.
Members of ICORN have an excellent track record in research ranging from bench science to health services research. This is amply demonstrated by the prolific publications relating to hepatitis C in the biomedical literature, although research activities and publications extend into many other areas also. The research activities are underpinned by network members having considerable success in securing European and local research funding to allow the active research programmes in each hospital to flourish. Members of ICORN are active contributors to the academic undergraduate and post-graduate programmes in the major universities in Ireland.